Linear Health Sciences Reports Clinical, Commercial Milestones
Linear Health Sciences has announced significant advancements for its Orchid SRV™, a breakthrough safety valve designed to enhance the use of medical tubing in hospital settings. Since its latest FDA…
Augustine Therapeutics Secures EUR 17 Million in Series A Funding to Propel Lead Candidate into Clinical Development for Neurological Diseases
Augustine Therapeutics, a pioneering biotech firm dedicated to advancing treatments for neurodegenerative and cardiometabolic diseases, has successfully closed its Series A funding round with EUR 17 million (USD 18.5 million).…
Cayuga Biotech Accelerates Life-Saving Hemorrhage Treatment with PolyP-SNP Complex, Promising 12x Faster Coagulation
Cayuga Biotech introduced groundbreaking preclinical findings today on its innovative polyphosphate (polyP)-based therapy aimed at combating life-threatening hemorrhage. The study revealed that the polyP-SNP (silica nanoparticle) complex accelerates thrombin production…
TVM Capital Healthcare Announces $35 Million Investment in Boston Oncology Arabia
TVM Capital Healthcare Announces $35 Million Investment in Boston Oncology Arabia TVM Capital Healthcare, an international healthcare expansion and growth capital firm, has announced a $35 million investment in Boston…
BioStrand and PGxAI Partner to Develop AI Model for Pharmacogenomics with LENSai
ImmunoPrecise Antibodies Ltd. (IPA), an AI-driven biotherapeutic research and technology company, announced a strategic collaboration between its subsidiary, BioStrand, and PGxAI. This partnership aims to leverage BioStrand’s patented LENSai Foundation…
PQE Group Introduces AI and Data Analytics Division: Pioneering Innovations in Life Science
PQE Group, a prominent consultancy in the Life Science sector, has announced the launch of its new Regulated Artificial Intelligence & Data Analytics division. This development follows the integration of…
Kenvue Unveils First-Ever Healthy Lives Mission Report
As the world’s largest pure-play consumer health company by revenue, Kenvue has released its first-ever Healthy Lives Mission Report, highlighting the company’s efforts to enhance the well-being of both people…
argenx Gets FDA Nod for VYVGART® with ENHANZE® for Chronic Inflammatory Demyelinating Polyneuropathy
argenx Receives FDA Approval for VYVGART® Hytrulo with ENHANZE® for Chronic Inflammatory Demyelinating Polyneuropathy Today, Halozyme announced that the U.S. Food and Drug Administration (FDA) has approved argenx’s VYVGART® Hytrulo…
Launch of Berlin Center for Gene and Cell Therapies in the Capital
Bayer AG and Charité – Universitätsmedizin Berlin Unveil Plans for Berlin Center Advancing Gene and Cell Therapies Today, Bayer AG and Charité – Universitätsmedizin Berlin announced their joint initiative to…
EU Approves Takeda’s FRUZAQLA for Treated Metastatic Colorectal Cancer
Takeda has announced that the European Commission (EC) has approved FRUZAQLA (fruquintinib) as a monotherapy for adult patients with metastatic colorectal cancer (mCRC) who have previously been treated with standard…
Takeda Unveils Promising Phase 2b Mezagitamab Data for Primary Immune Thrombocytopenia
Takeda today announced positive results from its Phase 2b, randomized, double-blind, placebo-controlled study evaluating the safety, tolerability, and efficacy of mezagitamab (TAK-079) in patients with persistent or chronic primary immune…
ISTH: Sanofi Strengthens Hemophilia Leadership with New Data on ALTUVIIIO and Fitusiran
Sanofi is set to present new data from its hemophilia portfolio at the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH), occurring from June 22-26, 2024, in…